Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FJLGW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,169
Award facts
- Contract value 100% obligated
- $12,168.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,168.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, with no set-aside designation applied. The product will be delivered to Park Ridge, Illinois, and represents a pharmaceutical supply requirement within the Defense Logistics Agency's medical procurement operations.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries across diverse therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FJLGW?
SPE2DB25FJLGW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FJLGW worth?
The government has obligated $12,169 on SPE2DB25FJLGW.
Is contract SPE2DB25FJLGW an order under another contract?
Yes. SPE2DB25FJLGW is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLGW competed?
The extent of competition for SPE2DB25FJLGW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award